Pharming Group N.V. (PHAR) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-12 15:12:21 ET
Pharming Group N.V. (PHAR) Q4 2025 Earnings Call March 12, 2026 8:30 AM EDT
Company Participants
Fabrice Chouraqui - CEO & Executive Director
Leverne Marsh - Chief Commercial Officer
Anurag Relan - Chief Medical Officer
Kenneth Lynard - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
Pharming Group N.V. (PHAR) Q4 2025 Earnings Call Transcript
Pharming Group N.V.
NASDAQ: PHGUF
PHGUF Trading
0.0% G/L:
$1.18 Last:
10,000 Volume:
$1.18 Open:
PHGUF Latest News
June 04, 2026 01:00:00 am
Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
May 22, 2026 03:30:00 pm
European Commission grants marketing authorization to Pharming's Joenja® (leniolisib) - the first approved treatment for APDS in the European Union
PHGUF Stock Data
$1,119,595,178
645,960,551
N/A
119
N/A
Biotechnology & Life Sciences
Healthcare
NL
Leiden
